PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$1.44B
1-Year Return
6.39%
This Quarter Return
+2.45%
1 Year Return
+6.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.8B
AUM Growth
+$33.2M
(+1.9%)
Cap. Flow
+$1.15M
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
1,653
New
573
Increased
246
Reduced
114
Closed
659
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$52.6M |
| 2 |
Union Pacific
UNP
|
$23.9M |
| 3 |
Booking.com
BKNG
|
$21.2M |
| 4 |
Boston Scientific
BSX
|
$20.7M |
| 5 |
Thermo Fisher Scientific
TMO
|
$19.9M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$121M |
| 2 |
Cigna
CI
|
$25.8M |
| 3 |
Lowe's Companies
LOW
|
$25M |
| 4 |
Philip Morris
PM
|
$24.2M |
| 5 |
Visa
V
|
$24.1M |
Sector Composition
| 1 | Technology | 17.37% |
| 2 | Healthcare | 14.63% |
| 3 | Consumer Discretionary | 14.54% |
| 4 | Financials | 13.37% |
| 5 | Industrials | 11.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
AMERISAFE
AMSF
$871M
| $170K | ﹤0.01% |
+3,193
| New | +$170K |
|
627
Simulations Plus
SLP
$279M
| $170K | ﹤0.01% |
+3,915
| New | +$170K |
|
628
Hamilton Lane
HLNE
$6.41B
| $169K | ﹤0.01% |
2,117
+940
| +80% | +$75.2K |
|
629
Natera
NTRA
$23.1B
| $168K | ﹤0.01% |
+3,453
| New | +$168K |
|
630
Unisys
UIS
$277M
| $167K | ﹤0.01% |
41,930
+26,130
| +165% | +$104K |
|
631
Omega Healthcare
OHI
$12.7B
| $166K | ﹤0.01% |
+5,420
| New | +$166K |
|
632
NovoCure
NVCR
$1.37B
| $165K | ﹤0.01% |
3,980
-11,798
| -75% | -$490K |
|
633
American Vanguard Corp
AVD
$159M
| $165K | ﹤0.01% |
+9,231
| New | +$165K |
|
634
Green Plains
GPRE
$698M
| $164K | ﹤0.01% |
+5,097
| New | +$164K |
|
|
BELFB
635
Bel Fuse Class B
BELFB
$1.82B
| $164K | ﹤0.01% |
+2,859
| New | +$164K |
|
|
SPWR
636
DELISTED
SunPower Corporation Common Stock
SPWR
| $164K | ﹤0.01% |
16,731
+550
| +3% | +$5.39K |
|
637
StepStone Group
STEP
$4.78B
| $164K | ﹤0.01% |
+6,597
| New | +$164K |
|
638
Gannett
GCI
$629M
| $163K | ﹤0.01% |
72,638
+68,866
| +1,826% | +$155K |
|
639
Usana Health Sciences
USNA
$581M
| $162K | ﹤0.01% |
+2,566
| New | +$162K |
|
640
Clearwater Paper
CLW
$354M
| $162K | ﹤0.01% |
+5,162
| New | +$162K |
|
641
Astec Industries
ASTE
$1.08B
| $160K | ﹤0.01% |
3,511
+3,369
| +2,373% | +$153K |
|
642
Halozyme
HALO
$8.76B
| $158K | ﹤0.01% |
+4,380
| New | +$158K |
|
|
TVRD
643
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $158K | ﹤0.01% |
1,550
+1,200
| +343% | +$122K |
|
644
Karyopharm Therapeutics
KPTI
$57.2M
| $154K | ﹤0.01% |
+5,729
| New | +$154K |
|
645
Wabash National
WNC
$479M
| $152K | ﹤0.01% |
5,928
-4,935
| -45% | -$127K |
|
646
Bloom Energy
BE
$13.4B
| $151K | ﹤0.01% |
9,266
-10,134
| -52% | -$166K |
|
647
Albany International
AIN
$1.84B
| $150K | ﹤0.01% |
1,606
-3,891
| -71% | -$363K |
|
648
CryoPort
CYRX
$518M
| $147K | ﹤0.01% |
+8,536
| New | +$147K |
|
649
Corcept Therapeutics
CORT
$7.31B
| $147K | ﹤0.01% |
6,602
-180
| -3% | -$4.01K |
|
650
Concentrix
CNXC
$3.39B
| $146K | ﹤0.01% |
1,808
-7,090
| -80% | -$573K |
|